Binliang Liu

6PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Artificial life and complex adaptive systemsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 12, 2026
Real-world efficacy and prognostic factors of CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer: a multicenter retrospective study from the Dongting Lake region of China.

Binliang Liu, Tao Wu, Kaili Lu

|Feb 02, 2026
AI and Big Data in Oncology: A Physician-Centered Perspective on Emerging Clinical and Research Applications.

Binliang Liu, Qingyao Shang, Jun Li

|Oct 28, 2024
Beyond clinical trials: CDK4/6 inhibitor efficacy predictors and nomogram model from real-world evidence in metastatic breast cancer.

Binliang Liu, Zhe-Yu Hu, Ning Xie

|Apr 13, 2022
Clinical and genetic predictions of early-onset cardiac toxicity in adjuvant chemotherapy for breast cancer.

Binliang Liu, Xiuwen Guan, Yanfeng Wang

|Apr 08, 2022
Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients.

Binliang Liu, Zongbi Yi, Yanfang Guan

|Dec 06, 2018
The association between early-onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple-negative breast cancer patients and some novel autophagy-related polymorphisms in their genomic DNA: a real-world study.

Binliang Liu, Tao An, Meiying Li

Pageof 1

Frequent Collaborators

2 joint publications

Xiuwen Guan

2 joint publications

Lixi Li

2 joint publications

Fei Ma

1 joint publications

Zongbi Yi